Acipimox
- Generic Name
- Acipimox
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H6N2O3
- CAS Number
- 51037-30-0
- Unique Ingredient Identifier
- K9AY9IR2SD
- Background
Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a mode...
- Indication
Used in the treatment of hyperlipidemias (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood).
- Associated Conditions
- Fredrickson classification type IV Hyperlipidemia, Fredrickson type IIb hyperlipidemia
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath